James Crowe
Faculty Member
Last active: 3/31/2020

  1. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. Yu X, McGraw PA, House FS, Crowe JE (2008) J Immunol Methods 336(2): 142-51
    › Primary publication · 18514220 (PubMed) · PMC2519117 (PubMed Central)
  2. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE (2008) J Virol 82(22): 11410-8
    › Primary publication · 18786987 (PubMed) · PMC2573258 (PubMed Central)
  3. Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE (2007) J Virol 81(24): 13710-22
    › Primary publication · 17928349 (PubMed) · PMC2168850 (PubMed Central)
  4. Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site. McKinney BA, Kallewaard NL, Crowe JE, Meiler J (2007) Immunome Res : 8
    › Primary publication · 17877819 (PubMed) · PMC2042970 (PubMed Central)
  5. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. Lee S, Miller SA, Wright DW, Rock MT, Crowe JE (2007) J Virol 81(5): 2349-58
    › Primary publication · 17182672 (PubMed) · PMC1865932 (PubMed Central)
  6. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE, Williams JV (2007) J Virol 81(2): 698-707
    › Primary publication · 17050599 (PubMed) · PMC1797435 (PubMed Central)
  7. Genetic predisposition for adverse events after vaccination. Crowe JE (2007) J Infect Dis 196(2): 176-7
    › Primary publication · 17570102 (PubMed)
  8. Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. Miller SA, Tollefson S, Crowe JE, Williams JV, Wright DW (2007) J Virol 81(1): 141-9
    › Primary publication · 17035305 (PubMed) · PMC1797239 (PubMed Central)
  9. Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells. Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE (2007) Mol Immunol 44(9): 2173-83
    › Primary publication · 17196657 (PubMed) · PMC1859862 (PubMed Central)
  10. Evaporative cooling feature selection for genotypic data involving interactions. McKinney BA, Reif DM, White BC, Crowe JE, Moore JH (2007) Bioinformatics 23(16): 2113-20
    › Primary publication · 17586549 (PubMed) · PMC3988427 (PubMed Central)